|
시장보고서
상품코드
1552516
호르몬 피임약 시장, 규모, 점유율, 동향, 산업 분석 보고서 : 제품별, 호르몬별, 유통 채널별, 지역별 - 시장 예측(2024-2032년)Hormonal Contraceptive Market Size, Share, Trends, Industry Analysis Report: By Product, By Hormone, By Distribution Channel, and By Region - Market Forecast, 2024 - 2032 |
||||||
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.
Polaris Market Research의 최신 조사에 따르면, 세계 호르몬 피임약 시장 규모는 2032년까지 246억 달러에 달할 것으로 예상됩니다. 이 조사 보고서는 현재 시장 역학에 대한 자세한 통찰력과 미래 시장 성장에 대한 분석을 제공합니다.
세계 호르몬 피임약 시장은 가족계획 및 생식보건에 대한 인식 증가, 신뢰할 수 있는 피임법으로서 호르몬 피임약의 채택률 증가, 피임기술의 발전 등으로 인해 강력한 성장세를 보이고 있습니다. 주요 촉진요인으로는 여성 건강 및 권한 부여에 대한 관심 증가, 피임약에 대한 접근성을 높이기 위한 정부 지원 정책 및 정책, 성병(STI) 예방 조치를 장려하는 성병(STI) 유병률 증가 등이 있습니다. 시장 동향은 장기 지속형 가역적 피임약(LARC)과 같은 혁신적인 호르몬 피임약으로의 전환과 경구용 피임약 및 호르몬 패치와 같은 개인화되고 편리한 대안에 대한 수요 증가를 보여줍니다.
신흥국의 호르몬 피임약 시장은 의료 인프라의 발전과 경제 상황의 개선에 힘입어 큰 폭으로 성장하고 있습니다. 또한, 의료 시스템에 대한 투자로 인해 다양한 피임 옵션에 대한 접근성이 확대되어 호르몬 피임약이 더 널리 보급되고 있습니다. 경제적 안정성이 높아짐에 따라 더 많은 사람들이 여유를 갖고 가족계획 서비스를 우선순위에 둘 수 있게 되었습니다. 또한, 생식 건강에 대한 인식과 교육이 높아지면서 수요 증가에 기여하고 있습니다. 정부 및 단체들도 공중보건 노력과 보조금을 통해 접근성을 개선하는 데 주력하고 있어 접근성을 더욱 향상시키고 있습니다. 이러한 시장 확대는 신흥국 여성들이 더 나은 생식 건강(성 및 생식 건강)에 대한 선택과 권한 부여에 대한 긍정적인 변화를 반영하고 있습니다.
호르몬 피임약 시장 보고서 하이라이트
경구 피임약은 널리 사용되고 효능이 확립되고 수년 동안 소비자에게 친숙하기 때문에 여전히 주요 분야입니다.
프로게스틴 단독 피임약, 임플란트, 주사 등의 방법을 포함한 프로게스틴 단독 피임약은 에스트로겐을 사용할 수 없거나 단독 호르몬 접근법을 선호하는 여성에게 적합하기 때문에 점점 더 인기를 얻고 있습니다.
현재 소매 약국이 시장을 독점하고 있는 것은 소비자들이 쉽게 이용할 수 있고 편리하기 때문입니다.
가장 빠르게 성장하고 있는 분야는 병원 약국입니다. 이러한 성장에는 의료 서비스에 대한 접근성 증가와 임상 현장에서 종합적인 생식 건강 서비스에 대한 관심이 높아진 것이 주요 요인으로 작용했습니다.
북미가 시장을 주도하고 아시아태평양이 가장 높은 성장률을 보일 것으로 예상됩니다.
목차
제1장 서론
제2장 주요 요약
제3장 조사 방법
제4장 세계의 호르몬 피임약 시장 인사이트
- 시장 현황
- 호르몬 피임약 시장 역학
- 성장 촉진요인과 기회
- 성장 억제요인과 과제
- PESTEL 분석
- 호르몬 피임약 시장 응용 동향
- 밸류체인 분석
- COVID-19의 영향 분석
제5장 세계의 호르몬 피임약 시장 : 제품별
- 주요 조사 결과
- 서론
- 정제
- 피부 패치
- 호르몬 임플란트
- 질링
- 피부 패치
- 기타
제6장 세계의 호르몬 피임약 시장 : 호르몬별
- 주요 조사 결과
- 서론
- 프로게스틴
- 복합 호르몬 피임약
제7장 세계의 호르몬 피임약 시장 : 유통 채널별
- 주요 조사 결과
- 서론
- 병원 약국
- 소매 약국
- 기타
제8장 세계의 호르몬 피임약 시장 : 지역별
- 주요 조사 결과
- 서론
- 호르몬 피임약 시장 평가 : 지역별, 2019-2032년
- 북미
- 북미 : 제품별, 2019-2032년
- 북미 : 호르몬별, 2019-2032년
- 북미 : 유통 채널별, 2019-2032년
- 미국
- 캐나다
- 유럽
- 유럽 : 제품별, 2019-2032년
- 유럽 : 호르몬별, 2019-2032년
- 유럽 : 유통 채널별, 2019-2032년
- 영국
- 프랑스
- 독일
- 이탈리아
- 스페인
- 네덜란드
- 러시아
- 기타 유럽
- 아시아태평양
- 아시아태평양 : 제품별, 2019-2032년
- 아시아태평양 : 호르몬별, 2019-2032년
- 아시아태평양 : 유통 채널별, 2019-2032년
- 중국
- 인도
- 말레이시아
- 일본
- 인도네시아
- 한국
- 호주
- 기타 아시아태평양
- 중동 및 아프리카
- 중동 및 아프리카 : 제품별, 2019-2032년
- 중동 및 아프리카 : 호르몬별, 2019-2032년
- 중동 및 아프리카 : 유통 채널별, 2019-2032년
- 사우디아라비아
- 아랍에미리트(UAE)
- 이스라엘
- 남아프리카공화국
- 기타 중동 및 아프리카
- 라틴아메리카
- 라틴아메리카 : 제품별, 2019-2032년
- 라틴아메리카 : 호르몬별, 2019-2032년
- 라틴아메리카 : 유통 채널별, 2019-2032년
- 멕시코
- 브라질
- 아르헨티나
- 기타 라틴아메리카
제9장 경쟁 구도
- 확대와 인수 분석
- 확대
- 인수
- 제휴/협업/합의/공개
제10장 기업 개요
- Bayer AG
- Pfizer Inc.
- Merck & Co., Inc.
- Johnson & Johnson
- AbbVie Inc.
- GlaxoSmithKline plc
- Mylan N.V.
- Teva Pharmaceutical Industries Ltd.
- Novartis AG
- HRA Pharma
- Mithra Pharmaceuticals
- Celgene Corporation
- Allergan plc
- Procter & Gamble Co.
- Reddy's Laboratories Ltd.
The global hormonal contraceptive market size is expected to reach USD 24.60 billion by 2032, according to a new study by Polaris Market Research. The report "Global Hormonal Contraceptive Market Size, Share, Trends, Industry Analysis Report: By Product (Pills, Skin Patches, Intrauterine Devices, Hormonal Implants, Vaginal Rings, and Others), By Hormone, By Distribution Channel, and By Region (North America, Europe, Asia-Pacific, Latin America and Middle East & Africa) - Market Forecast, 2024 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.
The global hormonal contraceptive market is experiencing robust growth, driven by increasing awareness about family planning and reproductive health, rising adoption of hormonal contraceptives as a reliable method of birth control, and advancements in contraceptive technology. Key drivers include the growing emphasis on women's health and empowerment, supportive government initiatives and policies promoting contraceptive access, and the rising prevalence of sexually transmitted infections (STIs), which encourages preventive measures. Trends in the market show a shift towards innovative hormonal contraceptives, such as long-acting reversible contraceptives (LARCs), and a rising demand for personalized and convenient options like oral contraceptives and hormonal patches.
The hormonal contraceptive market in emerging markets is experiencing significant growth, driven by advancements in healthcare infrastructure and improving economic conditions. Also, investment in healthcare systems, access to a variety of contraceptive options is expanding, making hormonal contraceptives more widely available. Enhanced economic stability allows more individuals to afford and prioritize family planning services. Additionally, increased awareness and education about reproductive health contribute to higher demand. Governments and organizations are also focusing on improving access through public health initiatives and subsidies, further boosting availability. This growing market reflects a positive shift towards better reproductive health options and empowerment for women in emerging economies.
Hormonal Contraceptive Market Report Highlight
Oral contraceptive pills remain the dominant segment due to their widespread use, well-established efficacy, and long-standing consumer familiarity.
Progestin-Only Contraceptives, which include methods like progestin-only pills, implants, and injections, are increasingly popular due to their suitability for women who cannot use estrogen or prefer a single-hormone approach.
Retail pharmacies currently dominate the market due to their widespread accessibility and convenience for consumers.
The highest-growing segment is hospital pharmacies. This growth is fueled by increasing healthcare access and a rising focus on comprehensive reproductive health services within clinical settings.
North America dominates the market, while Asia-Pacific is expected to witness the highest growth rate.
Polaris Market Research has segmented the Hormonal Contraceptive market report based on product, hormone, distribution channel and region
Hormonal Contraceptive, Product Outlook (Revenue - USD Billion, 2019 - 2032)
- Pills
- Skin Patches
- Intrauterine Devices
- Hormonal Implants
- Vaginal Rings
- Others
Hormonal Contraceptive, Hormone Outlook (Revenue - USD Billion, 2019 - 2032)
- Progestin Only
- Combined Hormone Contraceptives
Hormonal Contraceptive, Distribution Channel Outlook (Revenue - USD Billion, 2019 - 2032)
- Hospital Pharmacies
- Retail Pharmacies
- Others
Hormonal Contraceptive, Regional Outlook (Revenue - USD Billion, 2019 - 2032)
- North America
- US
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Netherlands
- Russia
- Rest of Europe
- Asia-Pacific
- China
- Japan
- India
- Malaysia
- South Korea
- Indonesia
- Australia
- Vietnam
- Rest of Asia-Pacific
- Middle East & Africa
- Saudi Arabia
- UAE
- Israel
- South Africa
- Rest of Middle East & Africa
- Latin America
- Mexico
- Brazil
- Argentina
- Rest of Latin America
Table of Contents
1. Introduction
- 1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
- 1.2. Stakeholders
2. Executive Summary
- 2.1. Market Highlights
3. Research Methodology
- 3.1. Overview
- 3.1.1. Data Mining
- 3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources
4. Global Hormonal Contraceptive Market Insights
- 4.1. Hormonal Contraceptive Market - Market Snapshot
- 4.2. Hormonal Contraceptive Market Dynamics
- 4.2.1. Drivers and Opportunities
- 4.2.1.1. Rising Demand for Long-Acting Reversible Contraceptives (LARCs) Is Driving the Market Growth
- 4.2.1.2. Shift Towards Personalized and Convenient Contraceptive Options Propels the Market
- 4.2.2. Restraints and Challenges
- 4.2.2.1. Health Concerns and Side Effects is hindering the Hormonal Contraceptive Market Growth
- 4.2.1. Drivers and Opportunities
- 4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
- 4.4. PESTEL Analysis
- 4.5. Hormonal Contraceptive Market Application Trends
- 4.6. Value Chain Analysis
- 4.7. COVID-19 Impact Analysis
5. Global Hormonal Contraceptive Market, by Product
- 5.1. Key Findings
- 5.2. Introduction
- 5.2.1. Global Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
- 5.3. Pills
- 5.3.1. Global Hormonal Contraceptive Market, by Pills, by Region, 2019-2032 (USD Billion)
- 5.4. Skin Patches
- 5.4.1. Global Hormonal Contraceptive Market, by Skin Patches, by Region, 2019-2032 (USD Billion)
- 5.5. Hormonal Implants
- 5.5.1. Global Hormonal Contraceptive Market, by Hormonal Implants, by Region, 2019-2032 (USD Billion)
- 5.6. Vaginal Rings
- 5.6.1. Global Hormonal Contraceptive Market, by Vaginal Rings, by Region, 2019-2032 (USD Billion)
- 5.7. Skin Patches
- 5.7.1. Global Hormonal Contraceptive Market, by Skin Patches, by Region, 2019-2032 (USD Billion)
- 5.8. Others
- 5.8.1. Global Hormonal Contraceptive Market, by Others, by Region, 2019-2032 (USD Billion)
6. Global Hormonal Contraceptive Market, by Hormone
- 6.1. Key Findings
- 6.2. Introduction
- 6.2.1. Global Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
- 6.3. Progestin Only
- 6.3.1. Global Hormonal Contraceptive Market, by Progestin Only, by Region, 2019-2032 (USD Billion)
- 6.4. Combined Hormone Contraceptives
- 6.4.1. Global Hormonal Contraceptive Market, by Combined Hormone Contraceptives, by Region, 2019-2032 (USD Billion)
7. Global Hormonal Contraceptive Market, by Distribution Channel
- 7.1. Key Findings
- 7.2. Introduction
- 7.2.1. Global Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
- 7.3. Hospital Pharmacies
- 7.3.1. Global Hormonal Contraceptive Market, by Hospital Pharmacies, by Region, 2019-2032 (USD Billion)
- 7.4. Retail Pharmacies
- 7.4.1. Global Hormonal Contraceptive Market, by Retail Pharmacies, by Region, 2019-2032 (USD Billion)
- 7.5. Others
- 7.5.1. Global Hormonal Contraceptive Market, by Others, by Region, 2019-2032 (USD Billion)
8. Global Hormonal Contraceptive Market, by Geography
- 8.1. Key Findings
- 8.2. Introduction
- 8.2.1. Hormonal Contraceptive Market Assessment, By Geography, 2019-2032 (USD Billion)
- 8.3. Hormonal Contraceptive Market - North America
- 8.3.1. North America: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
- 8.3.2. North America: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
- 8.3.3. North America: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.3.4. Hormonal Contraceptive Market - U.S.
- 8.3.4.1. U.S.: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
- 8.3.4.2. U.S.: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
- 8.3.4.3. U.S.: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.3.5. Hormonal Contraceptive Market - Canada
- 8.3.5.1. Canada: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
- 8.3.5.2. Canada: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
- 8.3.5.3. Canada: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.4. Hormonal Contraceptive Market - Europe
- 8.4.1. Europe: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
- 8.4.2. Europe: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
- 8.4.3. Europe: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.4.4. Hormonal Contraceptive Market - UK
- 8.4.4.1. UK: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
- 8.4.4.2. UK: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
- 8.4.4.3. UK: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.4.5. Hormonal Contraceptive Market - France
- 8.4.5.1. France: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
- 8.4.5.2. France: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
- 8.4.5.3. France: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.4.6. Hormonal Contraceptive Market - Germany
- 8.4.6.1. Germany: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
- 8.4.6.2. Germany: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
- 8.4.6.3. Germany: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.4.7. Hormonal Contraceptive Market - Italy
- 8.4.7.1. Italy: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
- 8.4.7.2. Italy: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
- 8.4.7.3. Italy: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.4.8. Hormonal Contraceptive Market - Spain
- 8.4.8.1. Spain: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
- 8.4.8.2. Spain: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
- 8.4.8.3. Spain: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.4.9. Hormonal Contraceptive Market - Netherlands
- 8.4.9.1. Netherlands: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
- 8.4.9.2. Netherlands: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
- 8.4.9.3. Netherlands: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.4.10. Hormonal Contraceptive Market - Russia
- 8.4.10.1. Russia: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
- 8.4.10.2. Russia: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
- 8.4.10.3. Russia: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.4.11. Hormonal Contraceptive Market - Rest of Europe
- 8.4.11.1. Rest of Europe: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
- 8.4.11.2. Rest of Europe: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
- 8.4.11.3. Rest of Europe: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.5. Hormonal Contraceptive Market - Asia Pacific
- 8.5.1. Asia Pacific: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
- 8.5.2. Asia Pacific: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
- 8.5.3. Asia Pacific: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.5.4. Hormonal Contraceptive Market - China
- 8.5.4.1. China: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
- 8.5.4.2. China: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
- 8.5.4.3. China: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.5.5. Hormonal Contraceptive Market - India
- 8.5.5.1. India: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
- 8.5.5.2. India: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
- 8.5.5.3. India: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.5.6. Hormonal Contraceptive Market - Malaysia
- 8.5.6.1. Malaysia: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
- 8.5.6.2. Malaysia: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
- 8.5.6.3. Malaysia: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.5.7. Hormonal Contraceptive Market - Japan
- 8.5.7.1. Japan: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
- 8.5.7.2. Japan: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
- 8.5.7.3. Japan: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.5.8. Hormonal Contraceptive Market - Indonesia
- 8.5.8.1. Indonesia: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
- 8.5.8.2. Indonesia: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
- 8.5.8.3. Indonesia: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.5.9. Hormonal Contraceptive Market - South Korea
- 8.5.9.1. South Korea: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
- 8.5.9.2. South Korea: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
- 8.5.9.3. South Korea: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.5.10. Hormonal Contraceptive Market - Australia
- 8.5.10.1. Australia: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
- 8.5.10.2. Australia: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
- 8.5.10.3. Australia: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.5.11. Hormonal Contraceptive Market - Rest of Asia Pacific
- 8.5.11.1. Rest of Asia Pacific: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
- 8.5.11.2. Rest of Asia Pacific: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
- 8.5.11.3. Rest of Asia Pacific: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.6. Hormonal Contraceptive Market - Middle East & Africa
- 8.6.1. Middle East & Africa: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
- 8.6.2. Middle East & Africa: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
- 8.6.3. Middle East & Africa: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.6.4. Hormonal Contraceptive Market - Saudi Arabia
- 8.6.4.1. Saudi Arabia: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
- 8.6.4.2. Saudi Arabia: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
- 8.6.4.3. Saudi Arabia: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.6.5. Hormonal Contraceptive Market - UAE
- 8.6.5.1. UAE: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
- 8.6.5.2. UAE: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
- 8.6.5.3. UAE: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.6.6. Hormonal Contraceptive Market - Israel
- 8.6.6.1. Israel: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
- 8.6.6.2. Israel: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
- 8.6.6.3. Israel: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.6.7. Hormonal Contraceptive Market - South Africa
- 8.6.7.1. South Africa: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
- 8.6.7.2. South Africa: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
- 8.6.7.3. South Africa: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.6.8. Hormonal Contraceptive Market - Rest of Middle East & Africa
- 8.6.8.1. Rest of Middle East & Africa: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
- 8.6.8.2. Rest of Middle East & Africa: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
- 8.6.8.3. Rest of Middle East & Africa: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.7. Hormonal Contraceptive Market - Latin America
- 8.7.1. Latin America: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
- 8.7.2. Latin America: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
- 8.7.3. Latin America: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.7.4. Hormonal Contraceptive Market - Mexico
- 8.7.4.1. Mexico: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
- 8.7.4.2. Mexico: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
- 8.7.4.3. Mexico: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.7.5. Hormonal Contraceptive Market - Brazil
- 8.7.5.1. Brazil: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
- 8.7.5.2. Brazil: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
- 8.7.5.3. Brazil: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.7.6. Hormonal Contraceptive Market - Argentina
- 8.7.6.1. Argentina: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
- 8.7.6.2. Argentina: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
- 8.7.6.3. Argentina: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.7.7. Hormonal Contraceptive Market - Rest of Latin America
- 8.7.7.1. Rest of Latin America: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
- 8.7.7.2. Rest of Latin America: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
- 8.7.7.3. Rest of Latin America: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
9. Competitive Landscape
- 9.1. Expansion and Acquisition Analysis
- 9.1.1. Expansion
- 9.1.2. Acquisitions
- 9.2. Partnerships/Collaborations/Agreements/Exhibitions
10. Company Profiles
- 10.1. Bayer AG
- 10.1.1. Company Overview
- 10.1.2. Financial Performance
- 10.1.3. Product Benchmarking
- 10.1.4. Recent Development
- 10.2. Pfizer Inc.
- 10.2.1. Company Overview
- 10.2.2. Financial Performance
- 10.2.3. Product Benchmarking
- 10.2.4. Recent Development
- 10.3. Merck & Co., Inc.
- 10.3.1. Company Overview
- 10.3.2. Financial Performance
- 10.3.3. Product Benchmarking
- 10.3.4. Recent Development
- 10.4. Johnson & Johnson
- 10.4.1. Company Overview
- 10.4.2. Financial Performance
- 10.4.3. Product Benchmarking
- 10.4.4. Recent Development
- 10.5. AbbVie Inc.
- 10.5.1. Company Overview
- 10.5.2. Financial Performance
- 10.5.3. Product Benchmarking
- 10.5.4. Recent Development
- 10.6. GlaxoSmithKline plc
- 10.6.1. Company Overview
- 10.6.2. Financial Performance
- 10.6.3. Product Benchmarking
- 10.6.4. Recent Development
- 10.7. Mylan N.V.
- 10.7.1. Company Overview
- 10.7.2. Financial Performance
- 10.7.3. Product Benchmarking
- 10.7.4. Recent Development
- 10.8. Teva Pharmaceutical Industries Ltd.
- 10.8.1. Company Overview
- 10.8.2. Financial Performance
- 10.8.3. Product Benchmarking
- 10.8.4. Recent Development
- 10.9. Novartis AG
- 10.9.1. Company Overview
- 10.9.2. Financial Performance
- 10.9.3. Product Benchmarking
- 10.9.4. Recent Development
- 10.10. HRA Pharma
- 10.10.1. Company Overview
- 10.10.2. Financial Performance
- 10.10.3. Product Benchmarking
- 10.10.4. Recent Development
- 10.11. Mithra Pharmaceuticals
- 10.11.1. Company Overview
- 10.11.2. Financial Performance
- 10.11.3. Product Benchmarking
- 10.11.4. Recent Development
- 10.12. Celgene Corporation
- 10.12.1. Company Overview
- 10.12.2. Financial Performance
- 10.12.3. Product Benchmarking
- 10.12.4. Recent Development
- 10.13. Allergan plc
- 10.13.1. Company Overview
- 10.13.2. Financial Performance
- 10.13.3. Product Benchmarking
- 10.13.4. Recent Development
- 10.14. Procter & Gamble Co.
- 10.14.1. Company Overview
- 10.14.2. Financial Performance
- 10.14.3. Product Benchmarking
- 10.14.4. Recent Development
- 10.15. Reddy's Laboratories Ltd.
- 10.15.1. Company Overview
- 10.15.2. Financial Performance
- 10.15.3. Product Benchmarking
- 10.15.4. Recent Development
샘플 요청 목록